848
Participants
Start Date
May 5, 2018
Primary Completion Date
December 31, 2023
Study Completion Date
July 26, 2024
Betamethason Sodium Phosphate
The antecorticosteroid that will be administered to Group 1 is betamethasone, produced by Dawon Parm(Korea). It contains betamethason sodium phosphate 5.2mg(Betamethasone 4.0mg) in 1 ample(1mL). Each drug is carried in a syringe by pharmacist who does not participate in study after the patient was enrolled in the study and administered to the patient twice 24hours apart.
Normal saline
Intramuscular injection of normal saline 3ml twice 24hours apart
Seoul National University Hospital, Seoul
Seoul National University Hospital
OTHER